References
- Bates B., Hardin J., Zhan X., Drickamer K., Goldfarb M. Biosynthesis of human fibro blast growth factor-5. Mol. Cell Biol. 1991; 11: 1840–1845
- Clements D. A., Wang J. K., Dionne C. A., Goldfarb M. Activation of fibroblast growth factor (FGF) receptors by recombinant human FGF-5. Oncogene 1993; 8: 1311–1316
- Coulier F., Batoz M., Marics I., de Lapeyriere O., Birnbaum D. Putative structure of the FGF6 gene product and role of the signal peptide. Oncogene 1991; 6: 1437–1444
- Hansen J. E., Lund O., Tolstrup N., Gooley A. A., Williams K. L., Brunak S. NetOglyc: prediction of mucin type O-glycosylation sites based on sequence context and surface accessibility. Glycoconjugate J. 1998; 15: 115–130
- Hase S., Ikenaka T., Matsushima Y. A highly sensitive method for analyses of sugar moieties of glycoproteins by fluorescence labeling. J. Biochem. (Tokyo) 1981; 90: 407–414
- Hsu Y. R., Hsu E. W., Katta V., Brankow D., Tseng J., Hu S., Morris C. F., Kenney W. C., Lu H. S. Human keratinocyte growth factor recombinantly expressed in Chinese hamster ovary cells: isolation of isoforms and characterization of post-translational modifications. Protein Expr. Purif. 1998; 12: 189–200
- Iida S., Yoshida T., Naito K., Sakamoto H., Katoh O., Hirohashi S., Sato T., Onda M., Sugimura T., Terada M. Human hst-2 (FGF-6) oncogene: cDNA cloning and characterization. Oncogene 1992; 7: 303–309
- Imamura T., Mitsui Y. Heparan sulfate and heparin as a potentiator or a suppressor of growth of normal and transformed vascular endothelial cells. Exp. Cell Res. 1987; 172: 92–100
- Kaufman R. J. Selection and coamplification of heterologous genes in mammalian cells. Methods Enzymol. 1990; 185: 537–566
- Mac Arthur C. A., Lawshe A., Shankar D. B., Heikinheimo M., Shackleford G. M. FGF-8 isoforms differ in NIH3T3 cell transforming potential. Cell Growth Differ. 1995; 6: 817–825
- Marics I., Adelaide J., Raybaud F., Mattei M. G., Coulier F., Planche J., de Lapeyriere O., Bimbaum D. Characterization of the HST-related FGF. 6 gene, a new member of the fibroblast growth factor gene family. Oncogene 1989; 4: 335–340
- Mc Keehan W. L., Wang F., Kan M. The heparan sulfate-fibroblast growth factor family: diversity of structure and function. Prog. Nucleic Acid Res. Mol. Biol. 1998; 59: 135–176
- Nielsen H., Engelbrecht J., Brunak S., von Heijne G. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng. 1997; 10: 1–6
- Ozawa K., Suzuki S., Asada M., Tomooka Y., Li A. J., Yoneda A., Komi A., Imamura T. An alternatively spliced fibroblast growth factor (FGF)-5 mRNA is abundant in brain and translates into a partial Agonist/Antagonist for FGF-5 neurotrophic activity. J. Biol. Chem. 1998; 273: 29262–29271
- Pizette S., Batoz M., Prats H., Bimbaum D., Coulier F. Production and functional characterization of human recombinant FGF-6 protein. Cell Growth Differ. 1991; 2: 561–566
- Santos-Ocampo S., Colvin J. S., Chellaiah A., Ornitz D. M. Expression and biological activity of mouse fibroblast growth factor-9. J. Biol. Chem. 1996; 19: 1726–1731
- Takasaki S., Mizuochi T., Kobata A. Hydrazinolysis of asparagine-linked sugar chains to produce free oligo-saccharides. Methods Enzymol. 1982; 83: 263–268